Cardiac markers in acute coronary syndrome
Reading File
Searching for cardiac markers in ACS across biochemical profiles, clinical utility, and diagnostic algorithms.
search_medical_text
cardiac biomarkers acute coronary syndrome troponin CK-MB myoglobin
Bailey and Love's Short Practice of Surgery 28th Edition
Page 969
search_medical_text
high sensitivity troponin diagnosis NSTEMI STEMI rise fall kinetics
Management of Acute Coronary Syndromes
Page 20
search_medical_image
cardiac biomarker release timeline acute myocardial infarction
GradeResponse
GradeResponse
GradeResponse
search_medical_text
0h 1h 2h 3h troponin algorithm rapid rule-out rule-in ACS ESC
search_medical_text
BNP NT-proBNP natriuretic peptides acute coronary syndrome prognosis risk stratification
Here is a comprehensive overview of cardiac markers in acute coronary syndrome (ACS), synthesized from the ESC Guidelines on Management of ACS, Bailey & Love's Surgery, and established clinical knowledge.
Cardiac Markers in Acute Coronary Syndrome
Overview
Cardiac biomarkers serve three roles in ACS:
- Diagnosis — confirm or exclude myocardial infarction
- Risk stratification — estimate prognosis and guide therapy
- Monitoring — assess infarct size and reperfusion
Key Cardiac Biomarkers
1. Cardiac Troponins (cTnI and cTnT) — Gold Standard
Troponins are structural proteins of the cardiac myofilament (part of the troponin-tropomyosin complex regulating actin-myosin interaction). They are highly cardiospecific.
| Feature | Detail |
|---|---|
| Rise begins | 2–4 hours after onset (1 hour with hs-cTn assays) |
| Peaks | 12–24 hours |
| Returns to baseline | 7–14 days (TnI), 10–14 days (TnT) |
| Diagnostic threshold | >99th percentile of healthy reference population |
| Preferred assay | High-sensitivity cardiac troponin (hs-cTn) |
High-Sensitivity Troponin (hs-cTn):
Per ESC ACS Guidelines, hs-cTn is recommended in all patients with suspected ACS (Management of Acute Coronary Syndromes, p. 20). It enables:
- Detection within 1 hour of symptom onset
- Significant rise and/or fall pattern distinguishes acute MI from chronic elevation
- Negative predictive value >99% when used in rapid algorithms
Fourth Universal Definition of MI criteria: A rise and/or fall in cTn above the 99th percentile of a healthy reference population, in the context of clinical ischaemia.
2. CK-MB (Creatine Kinase Myocardial Band)
| Feature | Detail |
|---|---|
| Rise begins | 4–6 hours |
| Peaks | 12–24 hours |
| Returns to baseline | 48–72 hours |
| Key advantage | Returns to normal faster than troponin → useful for detecting reinfarction |
| Limitation | Less cardiospecific than troponin (also in skeletal muscle) |
As noted in Bailey & Love's (p. 969), CK-MB remains a useful adjunct alongside troponin for both diagnosis and prognosis.
3. Myoglobin
| Feature | Detail |
|---|---|
| Rise begins | 1–3 hours (earliest marker) |
| Peaks | 6–9 hours |
| Returns to baseline | 24 hours |
| Advantage | Earliest to rise — useful for very early rule-out |
| Limitation | Very low specificity (also in skeletal muscle, renal failure) |
Largely replaced by hs-cTn in modern practice.
4. BNP / NT-proBNP (Natriuretic Peptides)
Not diagnostic of MI but used for risk stratification in ACS:
- Elevated levels indicate ventricular wall stress and dysfunction
- Predict mortality, heart failure, and adverse outcomes post-MI
- NT-proBNP elevation correlates with Killip class and infarct size
5. LDH (Lactate Dehydrogenase) — Historical
- Rises at 24–48 hours, peaks at 3–6 days, normalizes at 8–14 days
- Subtype LDH1 > LDH2 is cardiac-specific ("flipped LDH")
- No longer routinely used; superseded by troponin
Temporal Profile of Biomarkers After AMI
Hours after symptom onset:
0 2 4 6 12 24 48 72 7d 14d
| | | | | | | | | |
Myoglobin: [rises]--[peaks]--[normal]
CK-MB: [rises]--------[peaks]--[normal]
Troponin: [rises]--------------------[peaks]----------[normal]
ESC Rapid Algorithms (0h/1h/2h)
The ESC recommends hs-cTn-based rapid rule-out/rule-in protocols (ACS Guidelines, p. 20):
0h/1h Algorithm (preferred)
| Result | Interpretation | Action |
|---|---|---|
| hs-cTn very low at 0h | Rule-out | Discharge with outpatient follow-up |
| hs-cTn elevated + significant rise at 1h | Rule-in (MI) | Admit, treat as NSTEMI |
| Neither above | "Observe zone" | Repeat at 3h, clinical correlation |
0h/2h Algorithm (alternative)
- Absolute change in hs-cTn between 0h and 2h
- Validated cutoffs differ by assay (Elecsys, ARCHITECT, Dimension, etc.)
0h/3h Algorithm (when hs-cTn unavailable)
- Uses conventional troponin with sampling at 0h and 3h
Causes of Troponin Elevation Other Than Type 1 MI (Differential)
Elevated troponin is not synonymous with ACS. Other causes include:
| Cardiac | Non-Cardiac |
|---|---|
| Heart failure (acute/decompensated) | Pulmonary embolism |
| Myocarditis | Sepsis / critical illness |
| Takotsubo cardiomyopathy | Renal failure |
| Arrhythmias (AF, SVT) | Stroke / subarachnoid hemorrhage |
| Cardiac contusion | Rhabdomyolysis |
| Post-cardioversion | Extreme exertion |
This distinction is clinically critical — troponin must always be interpreted in context of symptoms, ECG, and clinical presentation.
Emerging / Investigational Markers
| Marker | Role |
|---|---|
| hsCRP | Inflammation marker; predicts risk in stable CAD and ACS |
| Copeptin | Combines with hs-cTn for very early rule-out at 0h (NSTEMI) |
| Heart-type fatty acid binding protein (H-FABP) | Early rise similar to myoglobin, higher specificity |
| Myeloperoxidase (MPO) | Plaque instability marker |
Summary Table
| Marker | Rises | Peaks | Normalizes | Specificity | Main Use |
|---|---|---|---|---|---|
| Myoglobin | 1–3h | 6–9h | 24h | Low | Early rule-out |
| CK-MB | 4–6h | 12–24h | 48–72h | Moderate | Reinfarction |
| Troponin I/T | 2–4h | 12–24h | 7–14d | High | Diagnosis/prognosis |
| hs-cTn | 1h | 12–24h | 7–14d | Very high | Rapid algorithms |
| BNP/NT-proBNP | Hours | Variable | Variable | N/A | Risk stratification |
| LDH | 24–48h | 3–6d | 8–14d | Low | Historical only |
Key Clinical Takeaways:
- hs-cTn is the biomarker of choice in all suspected ACS — use 0h/1h or 0h/2h algorithms
- A rise and/or fall pattern is required to distinguish acute from chronic troponin elevation
- CK-MB retains utility for suspected reinfarction (normalizes faster)
- Troponin elevation must always be interpreted with clinical context and ECG findings
- Negative troponin alone does not exclude unstable angina (no myocyte necrosis)
This is a shared conversation. Sign in to Orris to start your own chat.